Skip to main content

Table 4 Multiple Linear Regression Models# predicting the difference of means for each variable of interest between hyperuricemic and normouricemic groups

From: Prevalence of asymptomatic hyperuricemia and its association with prediabetes, dyslipidemia and subclinical inflammation markers among young healthy adults in Qatar

 

$Model 1

$Model 2

Parameter

Coefficient

95% CI

p-value

R 2

Coefficient

95% CI

p-value

R 2

Hemoglobin (g/dL)

-0.12

(-0.35, 0.11)

0.315

0.56

-0.14

(-0.39, 0.10)

0.259

0.57

Folate (nmol/L)

-0.55

(-1.81, 0.70)

0.389

0.03

-0.37

(-1.67, 0.93)

0.576

0.04

RBC (106/µL)

0.04

(-0.04, 0.12)

0.362

0.37

-0.01

(-0.10, 0.08)

0.785

0.35

TIBC (µmol/L)

0.07

(-1.54, 1.68)

0.934

0.18

0.00

(-1.72, 1.72)

0.999

0.19

WBC (103/µL)

0.16

(-0.20, 0.51)

0.386

0.00

-0.12

(-0.50, 0.26)

0.534

0.04

Monocytes (%)

-0.01

(-0.34, 0.32)

0.960

0.06

0.19

(-0.17, 0.54)

0.298

0.06

Platelet (103/µL)

8.82

(-2.32, 19.96)

0.121

0.11

-0.38

(-12.30, 11.54)

0.950

0.13

HDL (mmol/L)

-0.14

(-0.20, -0.08)

<0.001

0.21

-0.07

(-0.14, -0.01)

0.019

0.26

LDL (mmol/L)

0.18

(0.05, 0.31)

0.008

0.11

0.13

(-0.01, 0.27)

0.065

0.11

Triglycerides (mmol/L)

0.20

(0.09, 0.31)

0.001

0.13

0.12

(-0.01, 0.25)

0.066

0.15

 C-peptide (ng/mL)

0.75

(0.46, 1.04)

<0.001

0.05

0.38

(0.06, 0.69)

0.018

0.12

Glucose (mmol/L)

0.15

(0.02, 0.28)

0.021

0.05

0.06

(-0.08, 0.21)

0.395

0.07

HbA1c (%)

0.10

(0.02, 0.17)

0.011

0.04

0.04

(-0.04, 0.12)

0.358

0.07

*Ferritin (Males) (µg/L)

16.01

(1.93, 30.09)

0.026

0.04

8.08

(-7.18, 23.34)

0.298

0.07

*Ferritin (Females) (µg/L)

15.06

(0.19, 29.93)

0.047

0.01

13.72

(-0.27, 27.7)

0.054

0.00

MHR

0.62

(0.25, 1.00)

0.001

0.21

0.47

(0.06, 0.89)

0.026

0.21

  1. #The linear regression models were constructed using categorical uric acid groups where normouricemics were labeled 0 and hyperuricemics were labeled 1, and thus the coefficients displayed indicate the mean difference in the outcome variables between the hyperuricemic and normouricemic groups.
  2. $Model 1 is adjusted for age groups and sex. Model 2 is adjusted for age groups, sex, BMI, smoking and exercise. Adjusted R2 values have been displayed.
  3. *The regression models pertaining to ferritin were stratified by sex to avoid model misspecification.